Transcripts of PTTG and Growth Factors bFGF and IGF-1 are Correlated in Pituitary Adenomas

Abstract

The reasons for the increase of pituitary tumor-transforming gene (PTTG) transcripts in about 90% of pituitary adenomas are still not fully understood, although upregulation by basic fibroblast growth factor (bFGF) has been discussed as a potential cause. A possible influence of the Insulin like Growth Factor 1 (IGF-1) might be of interest, since this protein is also synthesized in most pituitary adenomas. Moreover, the principal regulation of the PTTG gene by IGF-1 and Insulin has been demonstrated in astrocytoma and breast cancer cells. We analyzed a large group (103 patients) of unselected clinical pituitary adenoma samples. From total RNA of frozen tumor samples (all subtypes) cDNA (complementary DNA) was synthesized and transcripts of PTTG, bFGF, IGF-1 were measured by Real-Time-PCR. Not only mRNA (messenger RNA) levels of bFGF, but also of IGF-1, correlated strongly with PTTG transcripts. This result was obtained, when all pituitary adenoma samples were included in the statistical calculations, irrespective of their subclassification. Our study suggests a connection between PTTG and IGF-1 in pituitary adenomas.

Key words

pituitary adenoma - PTTG - bFGF - IGF-1 - real-time PCR

References

• 1 Baird A, Mormède P, Ying SY. et al . A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion.  Proc Natl Acad Sci USA. 1985;  82 5545-5549
• 2 Castillo AI, Tolon RM, Aranda A. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.  Oncogene. 1998;  16 1981-1991
• 3 Chamaon K, Kirches E, Kanakis D. et al . Regulation of the pituitary tumor transforming gene by insulin-like growth factor-I and insulin differs between malignant and non-neoplastic astrocytes.  Biochem Biophys Res Commun. 2005;  331 ((1)) 86-92
• 4 Chien W, Pei L. A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product.  J Biol Chem. 2000;  275 19422-19427
• 5 Heaney AP, Horwitz GA, Wang Z. et al . Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.  Nat Med. 1999;  5 1317-1321
• 6 Heaney AP, Fernando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis.  J Clin Invest. 2002;  109 277-283
• 7 Horwitz GA, Miklovsky I, Heaney AP. et al . Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.  Mol Endocrinol. 2003;  17 600-609
• 8 Ishikawa H, Heaney AP, Yu R. et al . Human pituitary tumor-transforming gene induces angiogenesis.  J Clin Endocrinol Metab. 2001;  86 867-874
• 9 Kanakis D, Kirches E, Mawrin C. et al . Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas.  Clin Endocrinol (Oxf). 2003;  58 151-155
• 10 Karga HJ, Alexander JM, Hedley-Whyte ET. et al . Ras mutations in human pituitary tumors.  J Clin Endocrinol Metab. 1992;  74 914-919
• 11 LeRoith D, Baserga R, Helman L. et al . Insulin-like growth factors and cancer.  Ann Intern Med. 1995;  122 54-59
• 12 Lyons J, Landis CA, Harsh G. et al . Two G protein oncogenes in human endocrine tumors.  Science. 1990;  249 655-659
• 13 McCabe CJ, Khaira JS, Boelaert K. et al . Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.  Clin Endocrinol (Oxf). 2003;  58 141-150
• 14 Minematsu T, Suzuki M, Sanno N. et al . PTTG overexpression is correlated with angiogenesis in human pituitary adenomas.  Endocr Pathol. 2006;  17 143-153
• 15 Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications.  Oncology. 2002;  63 317-332
• 16 Otsuka F, Tamiya T, Yamauchi T. et al . Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.  Regul Pept. 1999;  83 31-38
• 17 Pei L, Melmed S, Scheithauer B. et al . H-ras mutations in human pituitary carcinoma metastases.  J Clin Endocrinol Metab. 1994;  78 842-846
• 18 Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG).  Mol Endocrinol. 1997;  11 433-441
• 19 Pei L. Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function.  J Biol Chem. 2000;  275 31191-31198
• 20 Piecha G, Chudek J, Wiecek A. Multiple Endocrine Neoplasia type 1.  Eur J Intern Med. 2008;  19 99-103
• 21 Sandberg AC, Engberg C, Lake M. et al . The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma.  Neurosci Lett. 1988;  93 114-119
• 22 Schweppe RE, Frazer-Abel AA, Gutierrez-Hartmann A. et al . Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene.  J Biol Chem. 1997;  272 30852-30859
• 23 Thompson 3rd AD, Kakar SS. Insulin and IGF-1 regulate the expression of the pituitary tumor transforming gene (PTTG) in breast tumor cells.  FEBS Lett. 2005;  579 3195-3200
• 24 Trojan LA, Kopinski P, Wei MX. et al . IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.  Acta Biochim Pol. 2002;  49 979-990
• 25 Vallar L, Spada A, Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas.  Nature. 1987;  330 566-568
• 26 Wang L, Adamo ML. Cell density influences insulin-like growth factor I gene expression in a cell type-specific manner.  Endocrinology. 2000;  141 2481-2489
• 27 Widhalm G, Woflsberger S, Preusser M. et al . O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?.  Cancer. 2009;  , [epub ahead of print]
• 28 Wierinckx A, Auger C, Devauchelle P. et al . A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors.  Endocr Relat Cancer. 2007;  14 887-900
• 29 Woloschak M, Roberts JL, Post K. c-myc, c-fos, and c-myb gene expression in human pituitary adenomas.  J Clin Endocrinol Metab. 1994;  79 253-257
• 30 Yamada S, Takada K. Angiogenesis in pituitary adenomas.  Microsc Res Tech. 2003;  60 236-243
• 31 Yong Y, Tan Y, Zhou C. et al . Pituitary tumor transforming gene interacts with SP1 to modulate G1/S cell phase transition.  Oncogene. 2007;  26 5596-5605
• 32 Zhang X, Horwitz GA, Prezant TR. et al . Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).  Mol Endocrinol. 1999;  13 156-166
• 33 Zhang X, Horwitz GA, Heaney AP. et al . Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.  J Clin Endocrinol Metab. 1999;  84 761-767
• 34 Zhu JL, Kaytor EN, Pao C-I. et al . Involvement of Sp1 in the transcriptional regulation of the rat insulin-like growth factor-I gene.  Mol Cell Endocrinol. 2000;  164 205-218

Correspondence